A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2019 9:00 AM EST
The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
Social and Behavioral Sciences
Embargo will expire:
12-Dec-2019 2:00 PM EST
Released to reporters:
9-Dec-2019 4:30 PM EST
EMBARGOED
A reporter's PressPass is required to access this story until the embargo expires on 12-Dec-2019 2:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
Cornell University's School of Hotel Administration has launched a Beer Essentials certificate program to help hospitality industry professionals develop the end-to-end understanding of beer production, tasting and selection necessary for establishing an effective beer program.
Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.
A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2019 8:00 AM EST
The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy
A roar of approval rang out at the U.S. Department of Energy’s (DOE’s) Argonne National Laboratory upon the announcement in October that John B. Goodenough, M. Stanley Whittingham and Akira Yoshino had won the 2019 Nobel Prize in Chemistry. On December 10th in Stockholm, they received this highly coveted prize for their major contributions to the invention of the lithium-ion battery, which is a long-standing major focus of research at Argonne.
At a conference held by the ReCell Center, an advanced battery recycling collaboration based at Argonne, representatives from industry, government, and academia discussed innovative approaches for lithium-ion battery recycling.
New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.
RSS Feeds by Section
